Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor (NYSE: AVTR) delivers essential materials and technologies powering breakthroughs in life sciences and advanced industries. This news hub provides investors and professionals with direct access to official announcements, including product innovations, financial results, and strategic partnerships shaping the future of bioprocessing and semiconductor manufacturing.
Track critical updates across Avantor's core operations: earnings disclosures detailing performance in pharmaceutical solutions, regulatory filings impacting global supply chains, and advancements in sustainable production methods like their viral vector processing systems. Discover how developments in brands like J.T. Baker and Macron Fine Chemicals influence research and manufacturing efficiency worldwide.
Our curated news collection serves as a decision-making tool for monitoring Avantor's role in enabling scientific progress across 180+ countries. Bookmark this page for real-time insights into leadership changes, facility expansions, and emerging applications in gene therapy support systems.
Avantor (NYSE: AVTR) announced it will release its Q1 2023 financial results before the market opens on April 28, 2023. A conference call will follow at 8:00 a.m. Eastern Time to discuss the results. The company is a leading provider of mission-critical products and services across various industries, including biopharma and healthcare. Avantor serves over 300,000 customer locations worldwide, reflecting its extensive reach in research and development.
For more details on the earnings call, visit ir.avantorsciences.com.
Avantor (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technologies sectors, announced management presentations at two major investor conferences. CFO Thomas Szlosek will present at the Raymond James 44th Annual Institutional Investors conference on March 6, 2023, at 1:40 p.m. EST in Orlando, Fla. Meanwhile, President & CEO Michael Stubblefield will engage in a fireside chat at Cowen's 43rd Annual Health Care conference on March 7, 2023, at 9:10 a.m. EST in Boston, Mass. Live audio webcasts will be accessible on Avantor's Investor Relations website, with replays available for 30 days.
Avantor, Inc. (NYSE: AVTR) reported its fourth-quarter and full-year 2022 financial results on February 3, 2023. The company achieved net sales of $1.80 billion for Q4, a 5.9% decline year-over-year, but saw core organic growth of 2.7%. Net income rose to $141.7 million. Full-year net sales reached $7.51 billion, up 1.7%, with core organic growth of 6.0%. Adjusted EBITDA was $1,570.7 million for the year, representing an 11.8% increase. Despite some regional sales decreases, strong performance in bioproduction and margin expansion were highlighted.
FAQ
What is the current stock price of Avantor (AVTR)?
What is the market cap of Avantor (AVTR)?
